This site is intended for healthcare professionals

Novartis announces positive results from a phase IV study showing superior tolerability and efficacy of Aimovig compared with topiramate in migraine prevention .

Read time: 2 mins
Last updated:3rd Nov 2020
Published:3rd Nov 2020
Condition: Migraine/Headache
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest